Penetration and bactericidal activity of cefixime in synovial fluid

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1198-1200

  Somekh, E ^a   Heifetz, L ^a   Dan, M ^a   Poch, F ^a   Hafeli, H ^a   Tanai, A ^a  

^a WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME;

ADULT; AGED; ARTHRITIS; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL ARTICLE; DRUG PENETRATION; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SYNOVIAL FLUID;

EID: 0029865320     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1198     Document Type: Article

References (8)

1. Brittain, D. C., B. E. Scully, T. Hirose, and H. C. Neu. 1985. The pharmacokinetic and bactericidal characteristics of oral cefixime. Clin. Pharmacol. Ther. 38:590-594.
2. Dan, M., and F. Poch. 1995. Comparison of serum bactericidal activities of newer oral cephalosporins. abstr. A94, p. 18. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Faulkner, R. D., P. Fernandez, G. Lawrence, L. L. Sia, A. J. Falkowski, A. J. Weiss, A. Yacobi, and B. M. Siber. 1988. Absolute bioavailability of cefixime in man J Clin. Pharmacol. 28:700-706.
4. Faulkner, R. D., W. Bohaychuk, R. E. Desjardins, Z. M. Look, and J. D. Haynes. 1987. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state. J. Clin. Pharmacol. 27:807-812.
5. Goto, S., F. Ikeda, M. Ogawa, S. Myazaki, and Y. Kaneko. 1985 In vitro and in vivo antibacterial activities of cefixime, a new oral cephalosporin. Chemotherapy 33(Suppl. 6):29-45.
6. Kaplan, L. S. 1994. Infections of the musculoskeletal system, p. 99-103. In L. S. Kaplan (ed.), Current therapy in pediatric infectious disease, 3rd ed. Mosby Year Book, Inc., St. Louis.
7. National Committee for Clinical Laboratory Standards. 1987. Proposed guidelines M26-P. Methods for determining bactericidal activity of antimicrobial agents. National Committee for Clinical Laboratory Standards, Villanova, Pa.
8. National Committee for Clinical Laboratory Standards. 1992. Tentative guidelines M21-T. Methodology for the serum bactericidal test. National Committee for Clinical Laboratory Standards, Villanova, Pa.